Yann Mazabraud Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

Yann Mazabraud is EVP, Head of International of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 40,370 shares of RYTM, which is worth approximately $2.19 Million. The most recent transaction as insider was on Mar 14, 2025, when has been sold 75,000 shares (Common Stock) at a price of $51.26 per share, resulting in proceeds of $3,844,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.4K

15.77% 3M change

64.81% 12M change

Total Value Held $2.19 Million

Yann Mazabraud Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 14 2025	SELL Open market or private sale	$3,844,500 $51.26 p/Share	75,000 Reduced 65.01%	40,370 Common Stock
Mar 14 2025	BUY Exercise of conversion of derivative security	$1,671,000 $22.28 p/Share	75,000 Added 39.4%	115,370 Common Stock
Feb 16 2025	BUY Exercise of conversion of derivative security	-	5,500 Added 11.99%	40,370 Common Stock
Apr 14 2024	SELL Exercise of conversion of derivative security	-	10,375 Reduced 22.93%	34,870 Common Stock
Mar 19 2024	SELL Open market or private sale	$627,520 $39.22 p/Share	16,000 Reduced 39.51%	24,495 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	33,750 Added 45.46%	40,495 Common Stock
Feb 13 2024	SELL Open market or private sale	$47,696 $49.84 p/Share	957 Reduced 12.43%	6,745 Common Stock
Feb 12 2024	SELL Open market or private sale	$81,899 $51.38 p/Share	1,594 Reduced 17.15%	7,702 Common Stock
Feb 11 2024	BUY Exercise of conversion of derivative security	-	2,031 Added 17.93%	9,296 Common Stock
Feb 09 2024	BUY Exercise of conversion of derivative security	-	3,438 Added 32.12%	7,265 Common Stock
Feb 14 2023	SELL Open market or private sale	$31,814 $27.03 p/Share	1,177 Reduced 23.52%	3,827 Common Stock
Feb 11 2023	BUY Exercise of conversion of derivative security	-	2,031 Added 28.87%	5,004 Common Stock
Feb 09 2023	SELL Open market or private sale	$42,817 $27.66 p/Share	1,548 Reduced 34.13%	2,988 Common Stock
Feb 09 2023	BUY Exercise of conversion of derivative security	-	3,438 Added 43.12%	4,536 Common Stock
Feb 15 2022	SELL Open market or private sale	$5,697 $6.1 p/Share	934 Reduced 45.96%	1,098 Common Stock
Feb 11 2022	BUY Exercise of conversion of derivative security	-	2,032 Added 50.0%	2,032 Common Stock

Yann Mazabraud

EVP, Head of International

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Value

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM

Account